Angion

0 followers


Angion is a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases.

Industries

Employees

11-50

Links


Org chart

Jay Venkatesan
President, CEO and Director
Collapse
Itzhak Goldberg
Executive Chairman & Chief Scientific Officer

Board & advisors

Joseph Bonventre
Scientific Advisor
Michael Koren
Scientific Advisor
Anupam Agarwal
Scientific Advisor
Sumit Mohan
Scientific Advisor
Jack Boyd
Scientific Advisor
Ken Newell
Scientific Advisor
Gregory P. Downey
Scientific Advisor
Matthew Cooper
Scientific Advisor
Matthew R. Weir
Scientific Advisor